These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15006494)

  • 61. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
    Advokat C
    Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential response of neurotensin to methamphetamine self-administration.
    Frankel PS; Hoonakker AJ; Hanson GR
    Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders.
    Tanganelli S; Antonelli T; Tomasini MC; Beggiato S; Fuxe K; Ferraro L
    Curr Med Chem; 2012; 19(3):304-16. PubMed ID: 22335510
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins.
    Griebel G
    Curr Pharm Des; 2015; 21(26):3807-12. PubMed ID: 26044977
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neurotensin: an endogenous antipsychotic?
    Kinkead B; Nemeroff CB
    Curr Opin Pharmacol; 2002 Feb; 2(1):99-103. PubMed ID: 11786316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interactions of neurotensin with dopamine-containing neurons in the central nervous system.
    Ervin GN; Nemeroff CB
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12 Suppl():S53-69. PubMed ID: 3074341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis.
    Ma D; Guest PC; Bahn S
    Bioanalysis; 2009 Dec; 1(9):1615-26. PubMed ID: 21083107
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The electrophysiological actions of neurotensin in the central nervous system.
    Stowe ZN; Nemeroff CB
    Life Sci; 1991; 49(14):987-1002. PubMed ID: 1890928
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia.
    Ritsner MS
    Neuroscience; 2011 Sep; 191():91-100. PubMed ID: 21549182
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Production of recombinant large proneurotensin/neuromedin N-derived peptides and characterization of their binding and biological activity.
    Friry C; Feliciangeli S; Richard F; Kitabgi P; Rovere C
    Biochem Biophys Res Commun; 2002 Feb; 290(4):1161-8. PubMed ID: 11811984
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.
    Nemeroff CB; Bissette G; Widerlov E; Beckmann H; Gerner R; Manberg PJ; Lindstrom L; Prange AJ; Gattaz WF
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):16-20. PubMed ID: 2577718
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emerging role of neurotensin in regulation of the cardiovascular system.
    Osadchii OE
    Eur J Pharmacol; 2015 Sep; 762():184-92. PubMed ID: 26004530
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Endocrine gene neurotensin: molecular mechanisms and a model of intestinal differentiation.
    Evers BM
    World J Surg; 2002 Jul; 26(7):799-805. PubMed ID: 11960215
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antipsychotics and neuropeptides: the atypical profile of CI-943 and its relationship to neurotensin.
    Liégeois JF; Bonaventure P; Delarge J; Damas J
    Neurosci Biobehav Rev; 1995; 19(4):519-31. PubMed ID: 8684714
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies.
    Nemeroff CB; Levant B; Myers B; Bissette G
    Ann N Y Acad Sci; 1992; 668():146-56. PubMed ID: 1361110
    [No Abstract]   [Full Text] [Related]  

  • 76. Dopamine and its relation to schizophrenia and antipsychotic drugs.
    Tarnoff GM
    Bull Menninger Clin; 1978 Jul; 42(4):321-38. PubMed ID: 29683
    [No Abstract]   [Full Text] [Related]  

  • 77. [Monoamine research--a productive field of particular importance in neuroscience].
    Carlsson A
    Lakartidningen; 1990 Nov; 87(45):3764, 3767-9. PubMed ID: 1977976
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diverse roles of neurotensin agonists in the central nervous system.
    Boules M; Li Z; Smith K; Fredrickson P; Richelson E
    Front Endocrinol (Lausanne); 2013; 4():36. PubMed ID: 23526754
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Progress in the development of neurokinin 3 modulators for the treatment of schizophrenia: molecule development and clinical progress.
    Dawson LA; Porter RA
    Future Med Chem; 2013 Sep; 5(13):1525-46. PubMed ID: 24024945
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Neuroleptics and dopamine. How the antipsychotic breakthrough resulted in improved knowledge about the biology of schizophrenia].
    Fog R
    Ugeskr Laeger; 2000 Jan; 162(1):68-9. PubMed ID: 10658506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.